Login / Signup

Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.

Shai LeviYotam BronsteinNeta GoldschmidtFortunato MorabitoTomer Ziv-BaranGiovanni Del PoetaOsnat BaireyMaria Ilaria Del PrincipeRiva FinemanFrancesca Romana MauroOdit GutweinGianluigi RedaRosa RuchlemerPaolo SportolettiLuca LaurentiLev ShvidelMarta CosciaTamar TadmorMarzia VarettoniAriel AvivRoberta MurruAndrei BraesterAnnalisa ChiarenzaAndrea VisentinDaniela PietrasantaGiacomo LosetoAntonella ZucchettoRiccardo BombenJacopo OlivieriAntonio NeriDavide RossiGianluca GaidanoLivio TrentinRobin FoàAntonio CuneoChava PerryValter GatteiMassimo GentileYair Herishanu
Published in: American journal of hematology (2022)
Keyphrases
  • chronic lymphocytic leukemia
  • high dose
  • cross sectional
  • clinical trial
  • diffuse large b cell lymphoma